0001209191-17-015069.txt : 20170227 0001209191-17-015069.hdr.sgml : 20170227 20170227215630 ACCESSION NUMBER: 0001209191-17-015069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170223 FILED AS OF DATE: 20170227 DATE AS OF CHANGE: 20170227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shak Steven CENTRAL INDEX KEY: 0001337334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 17644536 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-23 0 0001131324 GENOMIC HEALTH INC GHDX 0001337334 Shak Steven 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Scientific Officer Common Stock 2017-02-23 4 M 0 5000 23.31 A 336103 D Common Stock 2017-02-23 4 S 0 5000 29.363 D 331103 D Employee Stock Option (right to buy) 23.31 2017-02-23 4 M 0 5000 0.00 D 2017-12-06 Common Stock 0 20000 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2016. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $28.67 to $29.63. Includes an aggregate of 15,154 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The option became exercisable as to 25% of the shares on December 6, 2008, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2017-02-27